Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cytosorbents Corporation - Common Stock
(NQ:
CTSO
)
0.6800
-0.0094 (-1.36%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytosorbents Corporation - Common Stock
< Previous
1
2
3
4
5
6
Next >
Top movers in Tuesday's pre-market session
↗
December 23, 2025
As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Cytosorbents Corp (NASDAQ:CTSO) Posts Mixed Q3 2025 Results Amidst Stock Volatility
↗
November 13, 2025
Cytosorbents Q3 2025 earnings show a mixed quarter, beating EPS estimates but missing on revenue. The stock saw volatility despite a strengthened balance sheet.
Via
Chartmill
Cytosorbents (CTSO) Q3 2025 Earnings Transcript
↗
November 13, 2025
Cytosorbents (CTSO) Q3 2025 Earnings Transcript
Via
The Motley Fool
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
Deep Dive Into CytoSorbents Stock: Analyst Perspectives (5 Ratings)
↗
September 16, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
CytoSorbents's Earnings: A Preview
↗
May 13, 2025
Via
Benzinga
Insights into CytoSorbents's Upcoming Earnings
↗
March 28, 2025
Via
Benzinga
Expert Outlook: CytoSorbents Through The Eyes Of 7 Analysts
↗
January 13, 2025
Via
Benzinga
Wednesday's pre-market session: top gainers and losers
↗
August 20, 2025
As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 20, 2025
Via
Benzinga
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
↗
August 20, 2025
Via
Benzinga
Demystifying CytoSorbents: Insights From 5 Analyst Reviews
↗
August 08, 2025
Via
Benzinga
CytoSorbents Corp (NASDAQ:CTSO) Reports Mixed Q2 2025 Earnings with Revenue Beat and Narrower Loss
↗
August 07, 2025
CytoSorbents (CTSO) reported Q2 2025 results with revenue of $9.62M, beating estimates, and a narrower EPS loss of -$0.05. Shares rose 4.32% post-earnings amid steady demand for CytoSorb.
Via
Chartmill
A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts
↗
July 21, 2025
Via
Benzinga
Top movers in Wednesday's session
↗
July 02, 2025
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 02, 2025
Via
Benzinga
These stocks are moving in today's session
↗
July 02, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Gapping stocks in Wednesday's session
↗
July 02, 2025
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
Deep Dive Into CytoSorbents Stock: Analyst Perspectives (6 Ratings)
↗
June 25, 2025
Via
Benzinga
Demystifying CytoSorbents: Insights From 4 Analyst Reviews
↗
May 02, 2025
Via
Benzinga
Earnings Scheduled For May 14, 2025
↗
May 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 02, 2025
Via
Benzinga
The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts
↗
April 01, 2025
Via
Benzinga
Earnings Scheduled For March 31, 2025
↗
March 31, 2025
Via
Benzinga
CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller
March 04, 2025
The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024, and continues to expect regulatory decisions on DrugSorb™-ATR marketing...
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
February 26, 2025
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
February 25, 2025
1,417,208 Series A Right Warrants Exercised at $1.13 Per Share, Providing $1.6 Million in Aggregate Gross Proceeds
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
January 13, 2025
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai
January 06, 2025
From
CytoSorbents
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
